C.H.I.P.S. HOME PAGE
PHARMACEUTICAL SUBJECT LIST
TITLE LIST
MANUAL ORDER FORM
ONLINE ORDER FORM
QUESTIONS COMMENTS

Drug Therapy and Targeting Book from C.H.I.P.S.

Antiepileptic Drugs
Fifth Edition
edited by René H. Levy

The thoroughly revised, updated Fifth Edition of this classic is the most comprehensive, current, and authoritative reference on all anticonvulsants available today.

Antiepileptic Drugs features detailed profiles of newer drugs--including levetiracetam, oxcarbazepine, tiagabine, topiramate, and zonisamide--and new chapters on use of antiepileptic drugs in children and during pregnancy.

Drugs are covered in alphabetical order and in an easy-to-follow format: mechanisms of action; chemistry, biotransformation, and pharmacokinetics; interactions; clinical efficacy and use; and adverse effects.

Coverage of clinical use includes nonepileptic and psychiatric disorders where appropriate. This edition has been trimmed to manageable size by shortening chapters on older, less frequently used drugs.

Contents

  1. General Principles
    1. Principles of Antiepileptic Drug Action
    2. Neurophysiological Effects of Antiepileptic Drugs
    3. Discovery and Preclinical Development of Antiepileptic Drugs
    4. New Antiepileptic Drug Development: Medical Perspective
    5. Clinical Development of Antiepileptic Drugs: Industry Perspective
    6. The Development of Antiepilepsy Drugs: Regulatory Perspective
    7. Antiepileptic Drug Monotherapy in Adults: Selection and Use in New-Onset Epilepsy
    8. Combination Therapy and Drug Interactions
    9. Laboratory Monitoring of Antiepileptic Drugs
    10. Safety Monitoring of Antiepileptic Drugs
    11. Use of Antiepileptic Drugs in Children
    12. Antiepileptic Drug Use in Women
    13. Epilepsy in the Elderly
    14. Treatment of Status Epilepticus
    15. Prevention of Epileptogenesis

  2. Benzodiazepines
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, and Pharmacokinetics
    3. Clinical Efficacy and Use in Epilepsy
    4. Adverse Effects

  3. Carbamazepine
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, and Pharmacokinetics
    3. Interactions with Other Drugs
    4. Clinical Efficacy and Use in Epilepsy
    5. Clinical Efficacy and Use in Other Neurological Disorders
    6. Clinical Efficacy and Use in Psychiatric Disorders
    7. Adverse Effects

  4. Felbamate
    1. Felbamate

  5. Gabapentin
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, Pharmacokinetics, and Interactions
    3. Clinical Use
    4. Clinical Efficacy and Use in Other Neurological Disorders
    5. Clinical Efficacy and Use in Psychiatric Disorders
    6. Adverse Effects

  6. Lamotrigine
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, and Pharmacokinetics
    3. Interactions with Other Drugs
    4. Clinical Efficacy and Use in Epilepsy
    5. Efficacy and Use in Nonepileptic Disorders
    6. Adverse Effects

  7. Levetiracetam
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, Pharmacokinetics, and Drug Interactions
    3. Clinical Use
    4. Adverse Experiences

  8. Oxcarbazepine
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, and Pharmacokinetics
    3. Interactions with Other Drugs
    4. Clinical Efficacy and Use in Epilepsy
    5. Clinical Efficacy and Use in Psychiatric Disorders
    6. Adverse Effects

  9. Phenobarbital and Other Barbituates
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, and Pharmacokinetics
    3. Interactions with Other Drugs
    4. Clinical Efficacy and Use in Epilepsy
    5. Clinical Efficacy and Use in Nonepileptic Disorders
    6. Adverse Effects
    7. Methylphenobarbital

  10. Phenytoin and Other Hydantoins
    1. Mechanisms of Action
    2. Chemistry and Biotransformation
    3. Interactions with Other Drugs
    4. Clinical Efficacy and Use in Epilepsy
    5. Clinical Efficacy and Use in Other Neurological Disorders
    6. Clinical Efficacy and Use in Psychiatric Disorders
    7. Adverse Effects
    8. Fosphenytoin

  11. Primidone
    1. Primidone

  12. Succinimides
    1. Mechanisms of Action
    2. Ethosuximide: Chemistry, Biotransformation, Pharmacokinetics, and Drug Interactions
    3. Clinical Efficacy and Use in Epilepsy
    4. Adverse Effects
    5. Methsuximide

  13. Tiagabine
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, and Pharmacokinetics
    3. Drug Interactions
    4. Clinical Efficacy and Use in Epilepsy
    5. Clinical Efficacy and Use in Nonepileptic Disorders
    6. Adverse Effects

  14. Topiramate
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, and Pharmacokinetics
    3. Drug Interactions
    4. Clinical Efficacy and Use in Epilepsy
    5. Clinical Efficacy and Use in Nonepileptic Disorders
    6. Adverse Effects

  15. Valproic Acid
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, and Pharmacokinetics
    3. Drug Interactions
    4. Clinical Efficacy and Use in Epilepsy
    5. Clinical Efficacy and Use in Other Neurological Disorders
    6. Clinical Efficacy and Use in Psychiatric Disorders
    7. Adverse Effects

  16. Vigabatrin
    1. Vigabatrin

  17. Zonisamide
    1. Mechanisms of Action
    2. Chemistry, Biotransformation, and Pharmacokinetics
    3. Drug Interactions
    4. Clinical Efficacy and Use in Epilepsy
    5. Adverse Effects

  18. Drugs in Development
    1. Pregabalin
    2. Rufinamide
    3. Drugs in Early Clinical Development

Subject Index

click here to see books • videos • cd-roms of related interest

ORDER NOW

Antiepileptic Drugs 5th Edition
edited by René H. Levy
968 pages • $188.00 + shipping
Texas residents please add 6.75 % sales tax

Go to Top of Page

copyright © 1997-2009 Culinary and Hospitality Industry Publications Services